We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Gilead Again Pushes To Block Truvada Generic

Law360 (May 21, 2018, 3:06 PM EDT) -- Gilead Sciences Inc. and Emory University accused Aurobindo Pharma Ltd. in Delaware federal court Friday of infringing two of their patents covering the HIV treatment Truvada, the latest in a series of lawsuits attempting to block a generic version of the blockbuster drug.

Aurobindo infringed U.S. Patent Numbers 6,642,245 and 6,703,396 when it filed an abbreviated new drug application with the U.S. Food and Drug Administration hoping to get its generic approved, as both patents are still valid and enforceable, the suit says. The patents expire...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.